Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 466 AL 480

Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals

Chéramy M, Hampe CS, Ludvigsson J, Casas R.

Clin Exp Immunol. 2013 Mar;171(3):247-54. doi: 10.1111/cei.12026.

Teaching NeuroImages: PET-CT hypermetabolism paralleling muscle hyperactivity in stiff-person syndrome

O'Toole O, Murphy R, Tracy JA, McKeon A.

Neurology. 2013 Mar 5;80(10):e109. doi: 10.1212/WNL.0b013e3182840bad.

Stiff person syndrome improvement with chemotherapy in a patient with cutaneous T cell lymphoma

Rakocevic G, Hussain A.

Muscle Nerve. 2013 Jun;47(6):938-9. doi: 10.1002/mus.23706. Epub 2013 Apr 21.

Uncommon presentation of a common disorder

Sowmini PR, Jawahar M, Bhanu K.

Ann Indian Acad Neurol. 2013 Jan;16(1):111-3. doi: 10.4103/0972-2327.107720.

Antiglycine receptor-related stiff limb syndrome in a patient with chronic lymphocytic leukaemia

Derksen A, Stettner M, Stöcker W, Seitz RJ.

BMJ Case Rep. 2013 May 20;2013:bcr2013008667. doi: 10.1136/bcr-2013-008667.

Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant

Sengupta S, Tarsy D, Joyce R, Jeyapalan S.

Mov Disord. 2013 Nov;28(13):1905-6. doi: 10.1002/mds.25574. Epub 2013 Jul 9.

Orthostatic tremor heralding the onset of stiff-person syndrome

Vetrugno R, Fabbri M, Antelmi E, D'Angelo R, Rinaldi R.

Neurology. 2013 Oct 8;81(15):1361-2. doi: 10.1212/WNL.0b013e3182a8254f. Epub 2013 Sep 4.

Anesthesia considerations in stiff person syndrome

Sidransky MA, Tran NV, Kaye AD.

Middle East J Anaesthesiol. 2013 Jun;22(2):217-21.

[The stiff-person syndrome: a brief review and report of two cases]

Kemény Z, Pálfi P, Demeter J, Poór G, Kiss E, Bálint P.

Orv Hetil. 2013 Dec 1;154(50):1984-90. doi: 10.1556/OH.2013.29773.

An FP-CIT PET comparison of the differences in dopaminergic neuronal loss between idiopathic Parkinson disease with dementia and without dementia

Song IU, Kim YD, Cho HJ, Chung SW, Chung YA.

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):51-5. doi: 10.1097/WAD.0b013e31824acd84.

Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's disease

Roessler R, Boddeke E, Copray S.

Stem Cell Rev Rep. 2013 Aug;9(4):505-13. doi: 10.1007/s12015-012-9369-4.

Metabotropic glutamate receptors: a review on prospectives and therapeutic aspects

Vaidya A, Jain S, Jain AK, Agrawal A, Kashaw SK, Jain SK, Agrawal RK.

Mini Rev Med Chem. 2013 Nov;13(13):1967-81. doi: 10.2174/1389557511313130010.

The stigma scale for chronic illnesses 8-item version (SSCI-8): development, validation and use across neurological conditions

Molina Y, Choi SW, Cella D, Rao D.

Int J Behav Med. 2013 Sep;20(3):450-60. doi: 10.1007/s12529-012-9243-4.

From molecule to clinic and community for neurodegeneration: research to bridge translational gaps

Brayne C, Barker RA, Harold D, Ince PG, Savva GM, Williams J, Williams-Gray CH, Wharton SB.

J Alzheimers Dis. 2013;33 Suppl 1:S385-96. doi: 10.3233/JAD-2012-129006.

The pathophysiology of impulse control disorders in Parkinson disease

Balarajah S, Cavanna AE.

Behav Neurol. 2013;26(4):237-44. doi: 10.3233/BEN-2012-120266.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias